Jagsonpal Pharmaceuticals Ltd Share Price Today - Jagsonpal Pharmaceuticals Ltd Stock Price Live NSE/BSE

Jagsonpal Pharmaceuticals Ltd

NSE: JAGSNPHARM BSE: 507789

₹173.49

(-0.61%)

Wed, 18 Feb 2026, 00:28 am

MTF 5xInvest in Jagsonpal Pharmaceuticals Ltd with 5x Leverage Buy with MTF

Market Cap11.66B

PE Ratio28.33

Dividend1.43

Health Technology

Pharmaceuticals: Generic

24.5K

Jagsonpal Pharmaceuticals Share Price Live Chart

1 Day

0 (0%)

No Result Found

Summary

Market Cap
1178.94
Net Profit
55.36
P/B
5.99
Sector P/E
39.75
P/E
25.89
EV/EBITDA
16.65
Debt/Equity (Industry)
0.22
Interest Cover (Industry)
10.51
ROCE (Industry)
12.01
RONW (Industry)
11.72
ROE
18.58
ROCE
22.82
Debt/Equity
0.04
EPS (TTM)
6.37
Dividend Yield
1.41
Book Value
37.81
Interest Cover
53.26

Analysis

all

Pros

Dividends paid are thoroughly covered by earnings (14.2x coverage).
Jagsonpal Pharmaceuticals's pays a higher dividend yield than the bottom 25% of dividend payers in India (0.76%).
Jagsonpal Pharmaceuticals is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
Jagsonpal Pharmaceuticals is profitable, therefore cash runway is not a concern.
Jagsonpal Pharmaceuticals is profitable, therefore cash runway is not a concern.

Cons

No dividend growth in 10 years.
Dividends per share have been volatile in the past 10 years (annual drop of over 20%).
Jagsonpal Pharmaceuticals's dividend is below the markets top 25% of dividend payers in India (3.08%).
High level of physical assets or inventory.
Jagsonpal Pharmaceuticals is not covered by any analysts.

Financials

Ratios

Shareholders	DEC 2025	SEPT 2025	JUN 2025	MAR 2025	DEC 2024
Promoters	67.39	67.54	67.65	67.78	67.81
FII	2.12	2.12	2.18	2.10	2.10
DII	0.15	0.09	0.05	0.00	0.00
Public	30.34	30.25	30.12	30.11	30.08
Government	0	0	0	0	0

Technical Analysis

RSI

47.95

MACD

-1.50

50 DMA

183.92

200 DMA

219.24

Support and Resistance

Type	R3	R2	R1	PP	S1	S2	S3
Classic	252.94	212.94	190.88	172.94	150.88	132.94	92.94
Fibonacci	212.94	197.66	188.22	172.94	157.66	148.22	132.94
Camarilla	179.82	176.15	172.49	172.94	165.15	161.49	157.82

Pivots Level: Classic

+80

252.94

+40

212.94

+17.94

190.88

172.94

Pivot Point

LTP: 175.30

-22.06

150.88

-40

132.94

-80

92.94

Moving Average

SMAEMA

Period

Value

10-EMA
175.54
20-EMA
175.66
30-EMA
177.86
50-EMA
183.87
100-EMA
196.81
200-EMA
207.49

Announcement Date	Purpose	Action	Ex Date
21 Jan 2026	board-meetings	Quarterly Results
03 Nov 2025	board-meetings	Quarterly Results
26 Jul 2025	agm
06 May 2025	dividend	₹2.50 Dividend /Share	12 Sept 2025
23 Oct 2024	split	1:2.5 Splits of Equity Shares	08 Jan 2025
07 Aug 2024	agm
20 May 2024	dividend	₹5.00 Dividend /Share	06 Sept 2024
05 Aug 2023	agm
23 May 2023	dividend	₹5.00 Dividend /Share	21 Aug 2023
24 Aug 2022	agm

Jagsonpal Pharmaceuticals Ltd

Dr Reddys Laboratories Ltd

Torrent Pharmaceuticals Ltd

Divis Laboratories Ltd

Cipla Ltd

Sun Pharmaceutical Industries Ltd

Jagsonpal Pharmaceuticals Ltd About

Jagsonpal Pharmaceuticals engaged in the business of manufacturing and trading of pharmaceutical products and active pharmaceutical ingredients.

Industry

Pharmaceuticals - Indian - Bulk Drugs & Formln

Founded

1978

Headquarters

CEO

Harsha Raghavan

Employees

Contact

Website

http://www.jagsonpal.com

skmata@jagsonpal.com; cs@jagsonpal.com

Phone

91-011-46181100/46109900

Location

T-210 J, Shahpur Jat, New Delhi, New Delhi, 110049

Year	History
No Result Found

Client Name	Order Side	QTY	Avg Price	Date
HRTI PRIVATE LIMITED	Buy	350647	293.56	28 Jul 2025
GRAVITON RESEARCH CAPITAL LLP	Sell	498300	294.1	28 Jul 2025
HRTI PRIVATE LIMITED	Sell	343628	293.5	28 Jul 2025
GRAVITON RESEARCH CAPITAL LLP	Buy	498300	293.68	28 Jul 2025
ANKITA VISHAL SHAH	Buy	249425	775.17	29 Nov 2024
ANKITA VISHAL SHAH	Sell	154425	779.54	29 Nov 2024
INFINITY HOLDINGS	Sell	2200000	400	13 Sept 2024
INFINITY PORTFOLIO HOLDINGS	Buy	2200000	400	13 Sept 2024

Jagsonpal Pharmaceuticals Ltd News

Jagsonpal Pharma Outlines Growth Strategy for Next 2 Years

Jagsonpal Pharmaceutical expects 50% of growth from price increases and new products, with remaining from volume growth over the next one to two years during recent concall guidance.

23 Jan 2026

stocks

Jagsonpal Pharma Q3 FY26 Earnings Call Audio Available

Jagsonpal Pharmaceuticals has made available the audio recording of its Q3 FY26 earnings conference call held on January 22, 2026, discussing quarterly financial results.

22 Jan 2026

co actions results

Jagsonpal Pharma Q3FY26 Earnings Call on Jan 22

Jagsonpal Pharmaceuticals has scheduled an analyst and investor conference call on January 22, 2026, at 5:00 PM IST to discuss Q3FY26 financial results, hosted by Go India Advisors.

15 Jan 2026

co actions results

Jagsonpal Pharmaceuticals Allots 1.09L Equity Shares

Jagsonpal Pharmaceuticals Limited allotted 1,09,180 equity shares under ESOP 2022 to eligible employees, increasing paid-up capital from ₹13.36 crores to ₹13.38 crores.

06 Jan 2026

co actions results

Jagsonpal Pharma Receives ₹1.52 Cr GST Demand Order

Jagsonpal Pharmaceuticals receives tax demand order of ₹1.52 crores from Haryana State Tax authorities for FY 2021-22, plans to file appeal against the order.

30 Dec 2025

stocks

Open Your Free Demat Account Now!

Step into a world of zero fees and limitless opportunities!

Version -5.76

Stocks:

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Explore

Calculators

Popular Calculators

Group Stocks

Others:

NSE BSE CDSL NSDL SEBI MCX MSEI NCDEX NSE IFSC INDIA INX Account Closure Form DP Investor Charter Broker Investor Charter

Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800